Fibroblast Growth Factor 23 in Multiple Myeloma Patients with Renal Impairment

被引：0
作者：
Ibrahim, Nahed Moawad [1 ]
El Afifi, Amal Mostafa [1 ]
Abdelallim, Nada Shawky Rizk [1 ]
Abdullah, Nour El Hoda Hussein [1 ]
机构：
[1] Ain Shams Univ, Clin Hematol & Bone Marrow Transplantat Unit, Fac Med, Cairo, Egypt
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
MM; fibroblast growth factor 23; newly diagnosed multiple myeloma; renal impairment;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MM-299
引用
收藏
页码：S434 / S434
页数：1
相关论文
共 50 条
  • [31] Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents
    Dimopoulos, M. A.
    Delimpasi, S.
    Katodritou, E.
    Vassou, A.
    Kyrtsonis, M. C.
    Repousis, P.
    Kartasis, Z.
    Parcharidou, A.
    Michael, M.
    Michalis, E.
    Gika, D.
    Symeonidis, A.
    Pouli, A.
    Konstantopoulos, K.
    Terpos, E.
    Kastritis, E.
    ANNALS OF ONCOLOGY, 2014, 25 (01) : 195 - 200
  • [32] Management of renal complications in patients with advanced multiple myeloma
    Viertel, A
    Weidmann, E
    Ditting, T
    Geiger, H
    LEUKEMIA & LYMPHOMA, 2000, 38 (5-6) : 513 - 519
  • [33] Impact of dialysis dependence on survival for multiple myeloma with renal impairment: a multicenter study in China
    Jian, Yuan
    Zhou, Huixing
    Xie, Weiwei
    Ren, Yuan
    Zhang, Zhiyao
    Yang, Guangzhong
    Geng, Chuanying
    Jia, Jing
    Chen, Wenming
    Huang, Wenrong
    Cen, Xinan
    Gao, Wen
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (04): : 1571 - 1581
  • [34] Clinical and economic burden of medicare beneficiaries with multiple myeloma and renal impairment: An observational study
    Hari, Parameswaran
    Latremouille-Viau, Dominick
    Lin, Peggy
    Guerin, Annie
    Sasane, Medha
    MEDICINE, 2024, 103 (26) : e38609
  • [35] Diagnostic accuracy of fibroblast growth factor 23 for predicting acute kidney injury in patients with acute decompensated heart failure
    Pramong, Nattha
    Gojaseni, Pongsathorn
    Suttipongkeat, Sarunyoo
    Kiattisunthorn, Kraiwiporn
    Chittinandana, Anutra
    NEPHROLOGY, 2021, 26 (02) : 126 - 133
  • [36] Lenalidomide and dexamethasone for the treatment of refractory/relapsed multiple myeloma: dosing of lenalidomide according to renal function and effect on renal impairment
    Dimopoulos, Meletios A.
    Christoulas, Dimitrios
    Roussou, Maria
    Kastritis, Efstathios
    Migkou, Magdalini
    Gavriatopoulou, Maria
    Matsouka, Charis
    Mparmparoussi, Despoina
    Psimenou, Erasmia
    Grapsa, Irini
    Efstathiou, Eleni
    Terpos, Evangelos
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (01) : 1 - 5
  • [37] Impact of timing of stem cell return following high dose melphalan in multiple myeloma patients with renal impairment: a single center experience
    Nesr, George
    Shah, Raakhee
    Kyriakou, Charalampia
    Sive, Jonathan
    Popat, Rakesh
    Yong, Kwee
    Wisniowski, Brendan
    Xu, Ke
    Wechalekar, Ashu
    Lee, Lydia
    Ings, Stuart
    Papanikolaou, Xenofon
    Mahmood, Shameem
    Mcmillan, Annabel
    Horder, Jackie
    Newrick, Fiona
    Marfil, Jotham
    Ainley, Louise
    Asher, Samir
    Cheesman, Simon
    Rabin, Neil
    LEUKEMIA & LYMPHOMA, 2023, 64 (08) : 1465 - 1471
  • [38] Managing renal complications in multiple myeloma
    Fotiou, Despoina
    Dimopoulos, Meletios A.
    Kastritis, Efstathios
    EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (09) : 839 - 850
  • [39] Efficacy of Autologous Stem Cell Transplantation in Multiple Myeloma Patients with Renal Failure
    Firsova, Maya
    Mendeleeva, Larisa
    Solovev, Maxim
    Julhakyan, Hunan
    Savchenko, Valeriy
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S435 - S436
  • [40] Pomalidomide plus low-dose dexamethasone in patients with relapsed/refractory multiple myeloma and moderate renal impairment: a pooled analysis of three clinical trials
    Siegel, David S.
    Weisel, Katja C.
    Dimopoulos, Meletios A.
    Baz, Rachid
    Richardson, Paul
    Delforge, Michel
    Song, Kevin W.
    San Miguel, Jesus F.
    Moreau, Philippe
    Goldschmidt, Hartmut
    Cavo, Michele
    Jagannath, Sundar
    Yu, Xin
    Hong, Kevin
    Sternas, Lars
    Zaki, Mohamed
    Palumbo, Antonio
    LEUKEMIA & LYMPHOMA, 2016, 57 (12) : 2833 - 2838
12345